Drug Trial Radar · NCT04470128
A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Colonoscopy
Last checked: Nov 20, 2026Latest source record: Feb 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
180
Actual
Start
Aug 19, 2020
Primary completion
Dec 28, 2020
Study completion Jan 30, 2021
Sponsor
- Lead sponsor
- Haisco Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 14, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized, two-stage, phase II clinical study .The main objective is to evaluate the safety and tolerability of HSK21542 injection for analgesia in patients undergoing colonoscopy, and, combining the pharmacodynamic (PD) and pharmacokinetic (PK) characteristics
Conditions
- Analgesia
Interventions
Stage I: HSK21542 0.5 μg/kgDrug
intravenous injection
Stage I: HSK21542 1 μg/kgDrug
intravenous injection
HSK21542 0.5 μg/kgDrug
intravenous injection
HSK21542 1 μg/kgDrug
intravenous injection
HSK21542 2 μg/kgDrug
intravenous injection
PlaceboDrug
intravenous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- BPS-NI score>3 did not reach the proportionTime frame: From administration until 24 hours after administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
West China Hospital of Sichuan University
Chengdu, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.